Double-Blind and Placebo-Controlled Study of the Effectiveness and Safety of Extracorporeal Cardiac Shock Wave Therapy for Severe Angina Pectoris
-
- Kikuchi Yoku
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Ito Kenta
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Ito Yoshitaka
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Shiroto Takashi
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Tsuburaya Ryuji
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Aizawa Kentaro
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Hao Kiyotaka
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Fukumoto Yoshihiro
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Takahashi Jun
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Takeda Morihiko
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Nakayama Masaharu
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Yasuda Satoshi
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Kuriyama Shinichi
- Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine
-
- Tsuji Ichiro
- Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine
-
- Shimokawa Hiroaki
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
この論文をさがす
抄録
Background: Low-energy shock wave (SW) therapy has improved myocardial ischemia in both a porcine model and in patients with severe angina pectoris. Methods and Results: To further confirm the effectiveness and safety of SW therapy, 8 patients with severe angina pectoris were treated with SW therapy in a double-blind, placebo-controlled and cross-over manner. SW therapy, but not placebo, significantly improved chest pain symptoms and cardiac function without any complications or adverse effects. Conclusions: Extracorporeal cardiac SW therapy is an effective, safe and non-invasive therapeutic option for severe angina pectoris. (Circ J 2010; 74: 589 - 591)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 74 (3), 589-591, 2010
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205104724736
-
- NII論文ID
- 10025943921
-
- NII書誌ID
- AA11591968
-
- COI
- 1:STN:280:DC%2BC3c7js1yjsw%3D%3D
-
- ISSN
- 13474820
- 13469843
-
- PubMed
- 20134096
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可